{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T17:46:06Z","timestamp":1790358366701,"version":"4.1.0"},"reference-count":93,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Dermatologic Clinics"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.det.2024.12.002","type":"journal-article","created":{"date-parts":[[2025,1,21]],"date-time":"2025-01-21T12:51:11Z","timestamp":1737463871000},"page":"155-171","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Different Phenotypes of Hidradenitis Suppurativa"],"prefix":"10.1016","volume":"43","author":[{"given":"Vahide","family":"Saeidi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hessel","family":"Van der Zee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Sabat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afsaneh","family":"Alavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.det.2024.12.002_bib1","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1159\/000431175","article-title":"Hidradenitis suppurativa\/acne inversa: criteria for diagnosis, severity assessment, classification and disease evaluation","volume":"231","author":"Zouboulis","year":"2015","journal-title":"Dermatology"},{"issue":"1","key":"10.1016\/j.det.2024.12.002_bib3","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/s41572-020-0149-1","article-title":"Hidradenitis suppurativa","volume":"6","author":"Sabat","year":"2020","journal-title":"Nat Rev Dis Prim"},{"issue":"5","key":"10.1016\/j.det.2024.12.002_bib4","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1111\/ijd.16409","article-title":"Long-term risk of death in patients with hidradenitis suppurativa","volume":"62","author":"Kohorst","year":"2023","journal-title":"Int J Dermatol"},{"issue":"6","key":"10.1016\/j.det.2024.12.002_bib5","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1038\/jid.2012.472","article-title":"Identification of three hidradenitis suppurativa phenotypes: latent class analysis of a cross-sectional study","volume":"133","author":"Canoui-Poitrine","year":"2013","journal-title":"J\u00a0Invest Dermatol"},{"issue":"6","key":"10.1016\/j.det.2024.12.002_bib6","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1111\/jdv.16183","article-title":"Defining hidradenitis suppurativa phenotypes based on the elementary lesion pattern: results of a prospective study","volume":"34","author":"Martorell","year":"2020","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"issue":"5","key":"10.1016\/j.det.2024.12.002_bib7","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1046\/j.1468-3083.2000.00087.x","article-title":"The natural history of hidradenitis suppurativa","volume":"14","author":"von der Werth","year":"2000","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"issue":"6","key":"10.1016\/j.det.2024.12.002_bib8","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1111\/bjd.13147","article-title":"Hidradenitis suppurativa fulminans: a clinically distinct phenotype?","volume":"171","author":"Moriarty","year":"2014","journal-title":"Br J Dermatol"},{"issue":"5, Supplement 1","key":"10.1016\/j.det.2024.12.002_bib9","doi-asserted-by":"crossref","first-page":"AB150","DOI":"10.1016\/j.jaad.2015.02.616","article-title":"Phenotypic heterogeneity in hidradenitis suppurativa","volume":"72","author":"Martorell-Calatayud","year":"2015","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"5 Suppl 1","key":"10.1016\/j.det.2024.12.002_bib10","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1016\/j.jaad.2015.07.047","article-title":"New insights into the\u00a0diagnosis of hidradenitis suppurativa: clinical presentations and phenotypes","volume":"73","author":"van der Zee","year":"2015","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"8","key":"10.1016\/j.det.2024.12.002_bib11","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1111\/ced.12655","article-title":"Atypical hidradenitis suppurativa","volume":"40","author":"Naasan","year":"2015","journal-title":"Clin Exp Dermatol"},{"issue":"3","key":"10.1016\/j.det.2024.12.002_bib12","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1111\/bjd.17695","article-title":"Inter-rater reliability of phenotypes and exploratory genotype-phenotype analysis in inherited hidradenitis suppurativa","volume":"181","author":"Frew","year":"2019","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1016\/j.det.2024.12.002_bib13","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1159\/000511045","article-title":"Hidradenitis suppurativa: proposal of classification in two endotypes with two-step cluster analysis","volume":"237","author":"Gonzalez-Manso","year":"2021","journal-title":"Dermatology"},{"issue":"5","key":"10.1016\/j.det.2024.12.002_bib14","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1016\/j.jid.2020.08.032","article-title":"Characterization of hidradenitis suppurativa phenotypes: a multidimensional latent class analysis of the national Italian registry IRHIS","volume":"141","author":"Cazzaniga","year":"2021","journal-title":"J\u00a0Invest Dermatol"},{"issue":"2","key":"10.1016\/j.det.2024.12.002_bib15","first-page":"72","article-title":"Mammary hidradenitis suppurativa lesions - a suggestion for phenotyping","volume":"29","author":"Kjaersgaard Andersen","year":"2021","journal-title":"Acta Dermatovenerol Croat"},{"issue":"2","key":"10.1016\/j.det.2024.12.002_bib16","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s00403-020-02149-z","article-title":"Sub-classification of Hidradenitis suppurativa: a cross-sectional study","volume":"314","author":"Thorlacius","year":"2022","journal-title":"Arch Dermatol Res"},{"issue":"3","key":"10.1016\/j.det.2024.12.002_bib17","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1159\/000518965","article-title":"Prevalence and clinical characteristics of hidradenitis suppurativa phenotypes in a large Dutch cohort","volume":"238","author":"Dudink","year":"2022","journal-title":"Dermatology"},{"key":"10.1016\/j.det.2024.12.002_bib18","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2022.861241","article-title":"The genomic architecture of hidradenitis suppurativa-a systematic review","volume":"13","author":"Pace","year":"2022","journal-title":"Front Genet"},{"issue":"5","key":"10.1016\/j.det.2024.12.002_bib19","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.clindermatol.2023.08.025","article-title":"Hidradenitis suppurativa from the typical patient to the new clinical phenotypes","volume":"41","author":"Hristakieva","year":"2023","journal-title":"Clin Dermatol"},{"issue":"1","key":"10.1016\/j.det.2024.12.002_bib20","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/jvc2.89","article-title":"Cluster analysis identifies six clinical subtypes of hidradenitis suppurativa characterised by distinct comorbidities, inflammatory and metabolic profiles, patient-reported outcomes and treatment patterns","volume":"2","author":"J\u00f8rgensen","year":"2023","journal-title":"JEADV Clinical Practice"},{"issue":"5\u20136","key":"10.1016\/j.det.2024.12.002_bib21","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1159\/000491547","article-title":"Hurley III hidradenitis suppurativa has an aggressive disease course","volume":"234","author":"Vanlaerhoven","year":"2018","journal-title":"Dermatology"},{"key":"10.1016\/j.det.2024.12.002_bib22","series-title":"Dermatologic surgery : principles and practice","first-page":"729","article-title":"Axillary hyperhidrosis, apocrine bromhidrosis, hidradenitis suppurativa and familial benign pemphigus: surgical approach","author":"Hurley","year":"1989"},{"issue":"2","key":"10.1016\/j.det.2024.12.002_bib23","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.4049\/jimmunol.0903907","article-title":"Deficiency of IL-22 contributes to a chronic inflammatory disease: pathogenetic mechanisms in acne inversa","volume":"186","author":"Wolk","year":"2011","journal-title":"J\u00a0Immunol"},{"issue":"11","key":"10.1016\/j.det.2024.12.002_bib24","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1016\/j.jid.2017.05.033","article-title":"Hidradenitis suppurativa is characterized by dysregulation of the Th17:Treg cell axis, which is corrected by anti-TNF therapy","volume":"137","author":"Moran","year":"2017","journal-title":"J\u00a0Invest Dermatol"},{"issue":"6","key":"10.1016\/j.det.2024.12.002_bib25","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1016\/j.jid.2018.11.018","article-title":"The IL-1 pathway is hyperactive in hidradenitis suppurativa and contributes to skin infiltration and destruction","volume":"139","author":"Witte-Handel","year":"2019","journal-title":"J\u00a0Invest Dermatol"},{"issue":"2","key":"10.1016\/j.det.2024.12.002_bib26","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.jid.2022.08.051","article-title":"Disease association of anti\u2012carboxyethyl lysine autoantibodies in hidradenitis suppurativa","volume":"143","author":"Macchiarella","year":"2023","journal-title":"J\u00a0Invest Dermatol"},{"issue":"5","key":"10.1016\/j.det.2024.12.002_bib27","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1111\/bjd.15424","article-title":"Lipocalin-2 is expressed by activated granulocytes and keratinocytes in affected skin and reflects disease activity in acne inversa\/hidradenitis suppurativa","volume":"177","author":"Wolk","year":"2017","journal-title":"Br J Dermatol"},{"issue":"4","key":"10.1016\/j.det.2024.12.002_bib28","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/j.jaci.2022.10.034","article-title":"Neutrophilic granulocyte-derived B-cell activating factor supports B cells in skin lesions in hidradenitis suppurativa","volume":"151","author":"Sabat","year":"2023","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"4","key":"10.1016\/j.det.2024.12.002_bib29","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1111\/j.1365-2133.2009.09198.x","article-title":"Objective scoring of hidradenitis suppurativa reflecting the role of tobacco smoking and obesity","volume":"161","author":"Sartorius","year":"2009","journal-title":"Br J Dermatol"},{"issue":"12","key":"10.1016\/j.det.2024.12.002_bib30","doi-asserted-by":"crossref","first-page":"846","DOI":"10.7326\/0003-4819-157-12-201212180-00004","article-title":"Adalimumab for the treatment of moderate to severe Hidradenitis suppurativa: a parallel randomized trial","volume":"157","author":"Kimball","year":"2012","journal-title":"Ann Intern Med"},{"issue":"5","key":"10.1016\/j.det.2024.12.002_bib31","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1111\/bjd.15748","article-title":"Development and validation of the International Hidradenitis Suppurativa Severity Score System (IHS4), a novel dynamic scoring system to assess HS severity","volume":"177","author":"Zouboulis","year":"2017","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.det.2024.12.002_bib32","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2023.1145152","article-title":"Overview and comparison of the clinical scores in hidradenitis suppurativa: a real-life clinical data","volume":"10","author":"Daoud","year":"2023","journal-title":"Front Med"},{"issue":"5","key":"10.1016\/j.det.2024.12.002_bib33","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1111\/bjd.19565","article-title":"Hidradenitis suppurativa area and severity index revised (HASI-R): psychometric property assessment","volume":"184","author":"Goldfarb","year":"2021","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.det.2024.12.002_bib34","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/jdv.19481","article-title":"Hidradenitis suppurativa: detangling phenotypes and identifying common denominators","volume":"38","author":"Visan","year":"2024","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"issue":"5","key":"10.1016\/j.det.2024.12.002_bib35","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1159\/000508787","article-title":"Delayed diagnosis of hidradenitis suppurativa and its effect on patients and healthcare system","volume":"236","author":"Kokolakis","year":"2020","journal-title":"Dermatology"},{"issue":"4","key":"10.1016\/j.det.2024.12.002_bib36","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1001\/jamadermatol.2020.5467","article-title":"Global harmonization of morphological definitions in hidradenitis suppurativa for a proposed glossary","volume":"157","author":"Frew","year":"2021","journal-title":"JAMA Dermatol"},{"issue":"S1","key":"10.1016\/j.det.2024.12.002_bib37","first-page":"92","article-title":"Severe and fatal complications of the anogenital phenotype of hidradenitis suppurativa","volume":"31","author":"Deliyska","year":"2022","journal-title":"Exp Dermatol"},{"issue":"1","key":"10.1016\/j.det.2024.12.002_bib38","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/jdv.16677","article-title":"Hidradenitis suppurativa: an update on epidemiology, phenotypes, diagnosis, pathogenesis, comorbidities and quality of life","volume":"35","author":"Nguyen","year":"2021","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"issue":"2","key":"10.1016\/j.det.2024.12.002_bib39","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1177\/1203475420972348","article-title":"Race-specific prevalence of hidradenitis suppurativa","volume":"25","author":"Sachdeva","year":"2021","journal-title":"J\u00a0Cutan Med Surg"},{"issue":"11","key":"10.1016\/j.det.2024.12.002_bib40","doi-asserted-by":"crossref","first-page":"2842","DOI":"10.1038\/jid.2014.220","article-title":"Ethnicity and hidradenitis suppurativa","volume":"134","author":"Reeder","year":"2014","journal-title":"J\u00a0Invest Dermatol"},{"issue":"2","key":"10.1016\/j.det.2024.12.002_bib41","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1159\/000431037","article-title":"Hidradenitis suppurativa management in the United States: an analysis of the national ambulatory medical care survey and MarketScan medicaid databases","volume":"1","author":"Davis","year":"2015","journal-title":"Skin Appendage Disord"},{"issue":"6","key":"10.1016\/j.det.2024.12.002_bib42","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1159\/000486741","article-title":"Hidradenitis suppurativa: disease burden and etiology in skin of color","volume":"233","author":"Lee","year":"2017","journal-title":"Dermatology"},{"issue":"8","key":"10.1016\/j.det.2024.12.002_bib43","doi-asserted-by":"crossref","first-page":"990","DOI":"10.2340\/00015555-2176","article-title":"Hidradenitis suppurativa disproportionately affects African Americans: a single-center retrospective analysis","volume":"95","author":"Vlassova","year":"2015","journal-title":"Acta Derm Venereol"},{"issue":"6","key":"10.1016\/j.det.2024.12.002_bib44","doi-asserted-by":"crossref","DOI":"10.5070\/D3236035391","article-title":"Examining the race-specific prevalence of hidradenitis suppurativa at a large academic center; results from a retrospective chart review","volume":"23","author":"Vaidya","year":"2017","journal-title":"Dermatol Online J"},{"issue":"8","key":"10.1016\/j.det.2024.12.002_bib45","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1001\/jamadermatol.2017.0201","article-title":"Sex- and age-adjusted population analysis of prevalence estimates for hidradenitis suppurativa in the United States","volume":"153","author":"Garg","year":"2017","journal-title":"JAMA Dermatol"},{"issue":"3 Suppl","key":"10.1016\/j.det.2024.12.002_bib46","first-page":"92","article-title":"Hidradenitis suppurativa in Black and White patients - a clinical study","volume":"27","author":"Byrd","year":"2023","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.det.2024.12.002_bib47","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jdin.2021.01.007","article-title":"Hidradenitis suppurativa in patients of color is associated with increased disease severity and healthcare utilization: a retrospective analysis of 2 U.S. cohorts","volume":"3","author":"Kilgour","year":"2021","journal-title":"JAAD Int"},{"issue":"Suppl 1","key":"10.1016\/j.det.2024.12.002_bib48","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/exd.14341","article-title":"Hidradenitis suppurativa in skin of colour","volume":"30","author":"Zouboulis","year":"2021","journal-title":"Exp Dermatol"},{"issue":"6","key":"10.1016\/j.det.2024.12.002_bib49","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/j.jaad.2022.03.067","article-title":"Variations in genetics, biology, and phenotype of cutaneous disorders in skin of color. Part II: differences in clinical presentation and disparities in cutaneous disorders in skin of color","volume":"87","author":"McKenzie","year":"2022","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"12","key":"10.1016\/j.det.2024.12.002_bib50","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1111\/1346-8138.14656","article-title":"Demographic and clinical features of hidradenitis suppurativa in Korea","volume":"45","author":"Yang","year":"2018","journal-title":"J\u00a0Dermatol"},{"issue":"Suppl 1","key":"10.1016\/j.det.2024.12.002_bib51","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/exd.14340","article-title":"Hidradenitis suppurativa in South-East Asia and East Asia","volume":"30","author":"Chandran","year":"2021","journal-title":"Exp Dermatol"},{"issue":"11","key":"10.1016\/j.det.2024.12.002_bib52","doi-asserted-by":"crossref","first-page":"e440","DOI":"10.1111\/ijd.15293","article-title":"Trends in the management of hidradenitis suppurativa in the Middle East region: a systematic review","volume":"60","author":"Karvar","year":"2021","journal-title":"Int J Dermatol"},{"issue":"11","key":"10.1016\/j.det.2024.12.002_bib53","doi-asserted-by":"crossref","first-page":"e433","DOI":"10.1111\/ijd.15671","article-title":"Hidradenitis suppurativa in East and Southeast Asian populations: a systematic review and meta-analysis","volume":"60","author":"Gotesman","year":"2021","journal-title":"Int J Dermatol"},{"issue":"10","key":"10.1016\/j.det.2024.12.002_bib54","first-page":"17","article-title":"Hidradenitis suppurativa: causes, features, and current treatments","volume":"11","author":"Vinkel","year":"2018","journal-title":"J\u00a0Clin Aesthet Dermatol"},{"issue":"3","key":"10.1016\/j.det.2024.12.002_bib55","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1038\/jid.2012.372","article-title":"gamma-Secretase mutations in hidradenitis suppurativa: new insights into disease pathogenesis","volume":"133","author":"Pink","year":"2013","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.det.2024.12.002_bib56","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2022.1028943","article-title":"Sex-disaggregated population analysis in patients with hidradenitis suppurativa","volume":"9","author":"Sabat","year":"2022","journal-title":"Front Med"},{"key":"10.1016\/j.det.2024.12.002_bib57","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.2147\/CCID.S301794","article-title":"Obstacles to early diagnosis and treatment of hidradenitis suppurativa: current perspectives on improving clinical management","volume":"16","author":"Snyder","year":"2023","journal-title":"Clin Cosmet Investig Dermatol"},{"issue":"9","key":"10.1016\/j.det.2024.12.002_bib58","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1001\/jamadermatol.2021.2865","article-title":"Differences between children and adults with hidradenitis suppurativa","volume":"157","author":"Hallock","year":"2021","journal-title":"JAMA Dermatol"},{"issue":"3","key":"10.1016\/j.det.2024.12.002_bib59","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.jaad.2016.04.045","article-title":"Hidradenitis suppurativa (HS) and Down syndrome (DS): increased prevalence and a younger age of hidradenitis symptom onset","volume":"75","author":"Denny","year":"2016","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"1\u20132","key":"10.1016\/j.det.2024.12.002_bib60","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1159\/000487799","article-title":"Hidradenitis suppurativa associated with down syndrome is characterized by early age at diagnosis","volume":"234","author":"Giovanardi","year":"2018","journal-title":"Dermatology"},{"issue":"1","key":"10.1016\/j.det.2024.12.002_bib61","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/pde.14012","article-title":"Follicular occlusion disorders in Down syndrome patients","volume":"37","author":"Firsowicz","year":"2020","journal-title":"Pediatr Dermatol"},{"issue":"3","key":"10.1016\/j.det.2024.12.002_bib62","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1111\/bjd.15770","article-title":"Prevalence of hidradenitis suppurativa among patients with Down syndrome: a population-based cross-sectional analysis","volume":"178","author":"Garg","year":"2018","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.det.2024.12.002_bib63","doi-asserted-by":"crossref","DOI":"10.1111\/ijd.17261","article-title":"Demographics and treatment trends in the largest cohort of patients with Down syndrome and hidradenitis suppurativa","author":"Dao","year":"2024","journal-title":"Int J Dermatol"},{"issue":"1","key":"10.1016\/j.det.2024.12.002_bib64","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jaad.2020.08.045","article-title":"Hidradenitis suppurativa in pediatric patients","volume":"86","author":"Choi","year":"2022","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.det.2024.12.002_bib65","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1093\/ced\/llae030","article-title":"The impact of early-onset hidradenitis suppurativa","volume":"49","author":"Wolinska","year":"2024","journal-title":"Clin Exp Dermatol"},{"issue":"3","key":"10.1016\/j.det.2024.12.002_bib66","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.jaad.2014.11.017","article-title":"Correlation of early-onset hidradenitis suppurativa with stronger genetic susceptibility and more widespread involvement","volume":"72","author":"Deckers","year":"2015","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.det.2024.12.002_bib67","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1111\/ijd.13985","article-title":"A\u00a0retrospective study of the characteristics of patients with early-onset compared to adult-onset hidradenitis suppurativa","volume":"57","author":"Dessinioti","year":"2018","journal-title":"Int J Dermatol"},{"issue":"1","key":"10.1016\/j.det.2024.12.002_bib68","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1159\/000493465","article-title":"Adolescent-onset hidradenitis suppurativa: prevalence, risk factors and disease features","volume":"235","author":"Molina-Leyva","year":"2019","journal-title":"Dermatology"},{"issue":"6","key":"10.1016\/j.det.2024.12.002_bib69","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1016\/j.jaad.2020.04.022","article-title":"Patients with a familial predisposition to hidradenitis suppurativa have a distinct clinical phenotype","volume":"83","author":"Jorgensen","year":"2020","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.det.2024.12.002_bib70","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.jaad.2018.02.067","article-title":"Somatic and psychiatric comorbidities of hidradenitis suppurativa in children and adolescents","volume":"79","author":"Tiri","year":"2018","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.det.2024.12.002_bib71","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1016\/j.jaad.2020.05.090","article-title":"New-onset depression among children, adolescents, and adults with hidradenitis suppurativa","volume":"83","author":"Wright","year":"2020","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.det.2024.12.002_bib72","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.jaad.2019.08.034","article-title":"Association between obesity and hidradenitis suppurativa among children and adolescents: a population-based analysis in the United States","volume":"82","author":"Balgobind","year":"2020","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.det.2024.12.002_bib73","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1093\/bjd\/ljad317","article-title":"Hidradenitis suppurativa tarda: defining an understudied elderly population","volume":"190","author":"Koerts","year":"2023","journal-title":"Br J Dermatol"},{"issue":"2","key":"10.1016\/j.det.2024.12.002_bib74","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1093\/bjd\/ljad411","article-title":"Elderly male patients with hidradenitis suppurativa have more severe disease independent of disease duration","volume":"190","author":"Nielsen","year":"2024","journal-title":"Br J Dermatol"},{"issue":"2","key":"10.1016\/j.det.2024.12.002_bib75","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1001\/jamadermatol.2022.5390","article-title":"Hidradenitis suppurativa in older adults","volume":"159","author":"Blum","year":"2023","journal-title":"JAMA Dermatol"},{"issue":"8","key":"10.1016\/j.det.2024.12.002_bib76","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1001\/jamadermatol.2019.0478","article-title":"Distribution of self-reported hidradenitis suppurativa age at onset","volume":"155","author":"Naik","year":"2019","journal-title":"JAMA Dermatol"},{"issue":"5","key":"10.1016\/j.det.2024.12.002_bib77","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1159\/000531653","article-title":"Anemia and systemic inflammatory markers in patients with perianal disease: hidradenitis suppurativa and inflammatory bowel disease","volume":"239","author":"Yamanaka-Takaichi","year":"2023","journal-title":"Dermatology"},{"issue":"5","key":"10.1016\/j.det.2024.12.002_bib78","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1097\/AJP.0b013e3181ceb80c","article-title":"Painful hidradenitis suppurativa","volume":"26","author":"Smith","year":"2010","journal-title":"Clin J Pain"},{"key":"10.1016\/j.det.2024.12.002_bib79","series-title":"A Comprehensive Guide to Hidradenitis Suppurativa","first-page":"18","article-title":"3 - clinical manifestation and phenotypes of hidradenitis suppurativa","author":"Sachdeva","year":"2021"},{"key":"10.1016\/j.det.2024.12.002_bib80","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1060547","article-title":"A\u00a0rare loss-of-function genetic mutation suggest a role of dermcidin deficiency in hidradenitis suppurativa pathogenesis","volume":"13","author":"Tricarico","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.det.2024.12.002_bib81","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3389\/fmed.2017.00016","article-title":"Generalized comedones, acne, and hidradenitis suppurativa in a patient with an FGFR2 missense mutation","volume":"4","author":"Higgins","year":"2017","journal-title":"Front Med"},{"key":"10.1016\/j.det.2024.12.002_bib82","article-title":"Novel variants of MEFV and NOD2 genes in familial hidradenitis suppurativa: a case report","volume":"8","author":"Jfri","year":"2020","journal-title":"SAGE Open Med Case Rep"},{"issue":"6","key":"10.1016\/j.det.2024.12.002_bib83","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1111\/bjd.17466","article-title":"Association of pyrin mutations and autoinflammation with complex phenotype hidradenitis suppurativa: a case-control study","volume":"180","author":"Vural","year":"2019","journal-title":"Br J Dermatol"},{"issue":"11","key":"10.1016\/j.det.2024.12.002_bib84","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1111\/jdv.14464","article-title":"Recognizing syndromic hidradenitis suppurativa: a review of the literature","volume":"31","author":"Gasparic","year":"2017","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"issue":"6","key":"10.1016\/j.det.2024.12.002_bib85","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1111\/bjd.19812","article-title":"Development or exacerbation of hidradenitis suppurativa in two transgender men after initiation of testosterone therapy","volume":"184","author":"Buonomo","year":"2021","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.det.2024.12.002_bib86","first-page":"61","article-title":"Effects of biologic therapies for cutaneous inflammatory diseases in hiv-infected individuals: reliable or not?","volume":"2","author":"Akarsu","year":"2018","journal-title":"J\u00a0Basic Clin Health Sci"},{"issue":"11","key":"10.1016\/j.det.2024.12.002_bib87","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10112761","article-title":"Hidradenitis suppurativa in patients with hiv: a scoping review","volume":"10","author":"Macca","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.det.2024.12.002_bib88","first-page":"200","article-title":"[Hidradenitis suppurativa and psoriasis: manifestation of a hidden disease]","volume":"27","author":"Bouaddi","year":"2017","journal-title":"Pan Afr Med J"},{"issue":"20","key":"10.1016\/j.det.2024.12.002_bib89","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1001\/jama.2017.16691","article-title":"Hidradenitis suppurativa: advances in diagnosis and treatment","volume":"318","author":"Saunte","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.det.2024.12.002_bib90","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2021.676241","article-title":"Features associated with quality of life impairment in hidradenitis suppurativa patients","volume":"8","author":"Schneider-Burrus","year":"2021","journal-title":"Front Med"},{"issue":"1","key":"10.1016\/j.det.2024.12.002_bib91","doi-asserted-by":"crossref","DOI":"10.3390\/life11010034","article-title":"Quality-of-life impairment among patients with hidradenitis suppurativa: a cross-sectional study of 1795 patients","volume":"11","author":"Krajewski","year":"2021","journal-title":"Life"},{"issue":"16","key":"10.1016\/j.det.2024.12.002_bib92","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20163879","article-title":"Inflammation and cardiovascular diseases: the most recent findings","volume":"20","author":"Sorriento","year":"2019","journal-title":"Int J Mol Sci"},{"issue":"8","key":"10.1016\/j.det.2024.12.002_bib93","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1001\/jamadermatol.2020.1422","article-title":"Assessment of overall and specific cancer risks in patients with hidradenitis suppurativa","volume":"156","author":"Jung","year":"2020","journal-title":"JAMA Dermatol"},{"issue":"6","key":"10.1016\/j.det.2024.12.002_bib94","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1111\/bjd.19435","article-title":"The epidemiology of hidradenitis suppurativa","volume":"183","author":"Ingram","year":"2020","journal-title":"Br J Dermatol"}],"container-title":["Dermatologic Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733863524001025?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733863524001025?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T17:30:55Z","timestamp":1751391055000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0733863524001025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":93,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["S0733863524001025"],"URL":"https:\/\/doi.org\/10.1016\/j.det.2024.12.002","relation":{},"ISSN":["0733-8635"],"issn-type":[{"value":"0733-8635","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Different Phenotypes of Hidradenitis Suppurativa","name":"articletitle","label":"Article Title"},{"value":"Dermatologic Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.det.2024.12.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}